---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-003779"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2024-01-25T23:59:59+00:00"
generated_at: "2026-06-06T18:55:58.574359+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# AIM ImmunoTech furnishes supplemental data deck on pancreatic cancer Early Access Program

## Summary
- Deck titled 'Pancreatic Cancer Early Access Program Supplemental Data Q1 2024' furnished as Exhibit 99.1.
- Data posted on the 'Investors' section of the company's website.
- No specific clinical results or financial figures disclosed in the 8-K filing.

## SEC filing metadata
- accession: 0001493152-24-003779
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2024-01-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315224003779/0001493152-24-003779-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315224003779/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-003779
- JSON: https://secwatch.observer/filing/0001493152-24-003779.json
- Plain text: https://secwatch.observer/filing/0001493152-24-003779.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.